$3.01
+0.43 (+16.67%)
Open$2.64
Previous Close$2.58
Day High$3.08
Day Low$2.64
52W High$26.53
52W Low$18.74
Volume—
Avg Volume106.1K
Market Cap207.58M
P/E Ratio52.85
EPS$0.42
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+671.1% upside
Current
$3.01
$3.01
Target
$23.21
$23.21
$16.63
$23.21 avg
$31.03
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 29.54M | 29.63M | 31.10M |
| Net Income | -1,183,263 | -1,185,756 | -1,130,465 |
| Profit Margin | -4.0% | -4.0% | -3.6% |
| EBITDA | -1,626,848 | -1,569,658 | -1,729,159 |
| Free Cash Flow | -1,111,274 | -1,455,645 | -1,245,008 |
| Rev Growth | +3.0% | +20.7% | -3.6% |
| Debt/Equity | 0.73 | 0.75 | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |